CME Information
Jointly provided by Partners for Advancing Clinical Education (Partners) and MedliveCME, LLC (previously known as PlatformQ Health Education, LLC), in collaboration with Asthma and Allergy Foundation of America (AAFA).
Acknowledgement
This program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi.
Credits Available
- Physicians — maximum of 0.75 AMA PRA Category 1 Credit(s)™
All other healthcare professionals completing this course will be issued a statement of participation.
Date of Release/Expiration
This activity was released on November 17th, 2025, and is valid until November 17th, 2026. Requests for credit must be made no later than November 17th, 2026.
Target Audience
The primary target audience for this activity are ENTs and allergy/immunology clinicians.
Program Overview
Patients’ safety and quality of life can be severely impacted by smell dysfunction related to chronic rhinosinusitis with nasal polyps (CRSwNP). A panel of expert clinicians will review new data on the role of type 2 cytokines in the pathophysiology of CRSwNP and anosmia. Panelists will also share evidence-based strategies to improve olfactory dysfunction in CRSwNP and individualize treatment.
Learning Objectives
After completing this activity, the participant should be better able to:
- Identify the role of type 2 cytokines in the pathogenesis of olfactory dysfunction in CRSwNP
- Apply the latest evidence-based strategies for CRSwNP with a focus on restoring olfactory function
Faculty
Kathleen Buchheit, MD
Associate Physician
Brigham and Women's Hospital
Zachary M. Soler, MD, MSc
Professor
Otolaryngology Head and Neck Surgery
Medical University of South Carolina
Parker Happ
Type II Patient (AERD)
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and MedliveCME, LLC (previously known as PlatformQ Health Education, LLC). Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Education
Partners designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Estimated Time to Complete
This activity should take approximately 45 minutes to complete.
Instructions to Receive Credit
In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a score of 75% on the post-test.
Hardward/Software Requirements
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
Fee Information & Refund/Cancellation Policy
There is no fee for this educational activity.
Faculty and Disclosure of Conflicts of Interest
Partners requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Medlive Privacy Policy
Contact Information
Accreditation Support:
For additional information about the accreditation of this activity, please visit https://partnersed.com.
Technical Support:
For any technical issues or issues with your CME Certificate, please contact Medlive at 877-394-1306 or at [email protected].